Who are we?
The Solabia group is a producer of raw materials for the cosmetics, pharmaceutical, nutraceutical and biotechnology industries.
The Solabia group is a producer of raw materials for the cosmetics, pharmaceutical, nutraceutical and biotechnology industries.
Solabia provides its customers with a wide range of ingredients and active ingredients to improve the health or beauty of consumers. The Solabia Group’s activity does not stop there, as it also produces a range of culture media and diagnostic kits for microbiological control. In all these sectors, consumption is evolving quickly, resulting in profound societal changes, combined with the search for a more environmentally friendly life and an increased demand for transparency.
By making corporate social responsibility (CSR) one of its priorities, our group has confirmed its commitment to sustainable development. All the company’s resources are mobilized to meet economic, social and environmental challenges and to build a more responsible future together.
Solabia’s strategy is focused on innovation, a strong investment policy, and the mobilization of all its teams, thus enabling the group to achieve its objectives: to meet the requirements of its customers and its various markets. In three decades, Solabia has become an international group, the result of perfectly controlled external and internal growth. Through the recent acquisition of Laborclin, Bioactor and AppleChem.
Dutch company founded in 2011, which works in close relationship with the Medical Center of Maastricht University and NUTRIM, the largest research faculty in nutrition and health in the Netherlands. Bioactor positions itself on the Nutrition market, through original ingredients recognized for their health benefits.
American company founded in 2003 that develops and supplies a range of ingredients to improve the quality of a wide range of products. With a focus on functional ingredients and sun dispersions, AppleChem offers unique and innovative solutions for the cosmetics industry.
Founded in 1972 by Mr. Gérard Josset, the Solabia group has more than 50 years of experience in the pharmaceutical, nutrition, cosmetics and biotechnological industries. Over the decades, Solabia has decided to expand its offer and respond to a constantly evolving market through several acquisitions with varied and complementary expertise. Indeed, these strategic acquisitions represent one of the key levers of the Solabia Group’s growth and an undeniable opportunity to stand out on future markets while preserving the long-term stability of the Group as a whole.
Brazilian Subsidiary Established
BioEurope Acquisition
Brazilian Factories Established
German Subsidiary Established
Algatech Acquisition
Bioactor Acquisition
Solabia Established
CEP Acquisition
UCIB Acquisition
USA Subsidiary Established
Algues & Mer Acquisition
Laborclin Acquisition
AppleChem Acquisition
Solabia Established
Brazilian Subsidiary Established
CEP Acquisition
BioEurope Acquisition
UCIB Acquisition
Brazilian Factories Established
USA Subsidiary Established
German Subsidiary Established
Algues & Mer Acquisition
Algatech Acquisition
Laborclin Acquisition
Bioactor Acquisition
AppleChem Acquisition